Navigation Links
EMBO welcomes 55 leading life scientists as members

Heidelberg, Germany, 9 May 2012 Fifty-five life scientists from Europe and around the world were today recognised by EMBO for their excellence in research. Forty-eight of the researchers are from Europe and neighbouring countries while seven scientists from Argentina, Australia, South Korea and the United States join as Associate Members. In total, EMBO membership now comprises almost 1,550 life scientists in the international scientific community.

EMBO elects new members annually on the basis of scientific excellence. The new members represent a broad cross-section of the life sciences. The latest scientists to join the group come from 17 different countries and include 13 female scientists recognized for their contributions to life science research.

The new nominees include the first ever Associate Members in South Korea and Argentina. "Our members are the basis for the excellent international reputation of EMBO and its increasingly global orientation. We welcome this group of exceptional scientists and look forward to their fresh input and ideas," said EMBO Director Maria Leptin.

The selected researchers will help shape the direction of the life sciences in Europe and beyond by their involvement with the activities of the organization. EMBO Members provide scientific input such as acting on advisory editorial boards of the four scientific journals of the organization, serving on selection committees for EMBO Programmes and giving general advice to the scientific community.

A list of all new EMBO Members and Associate Members accompanies this announcement.

European Molecular Biology Organization

Page: 1

Related biology news :

1. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
2. Chinas new Climate Center welcomes citizen scientists
3. Agronomy Society welcomes USDA Mississippi River Basin Initiative
4. Chip Supply Welcomes Lupton Associates to Sales Team
5. March of Dimes welcomes FDA approval of progesterone injections
6. National Zoo Welcomes Whooping Crane
7. Society of Interventional Radiology Foundation welcomes corporate gift from Sirtex Medical
8. EMBO honors 59 leading life scientists
9. UCSF Fresno leading-edge study lends hope to emphysema patients
10. Scientists identify cell changes leading to impaired artificial kidney function
11. InvoTech Selects M2SYS Technology for Leading-Edge Fingerprint Software Solution
Post Your Comments:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... FRANCISCO , June 23, 2016   EpiBiome ... has secured $1 million in debt financing from Silicon ... ramp up automation and to advance its drug development ... its new facility. "SVB has been an ... beyond the services a traditional bank would provide," said ...
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology: